CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Clinical Outcomes of N1b Papillary Thyroid Cancer Patients Treated with Two Different Doses of Radioiodine Ablation Therapy
Meihua Jin, Jonghwa Ahn, Yu-Mi Lee, Tae-Yon Sung, Won Gu Kim, Tae Yong Kim, Jin-Sook Ryu, Won Bae Kim, Young Kee Shong, Min Ji Jeon
Endocrinol Metab. 2020;35(3):602-609.   Published online September 22, 2020
DOI: https://doi.org/10.3803/EnM.2020.741

Excel Download

Clinical Outcomes of N1b Papillary Thyroid Cancer Patients Treated with Two Different Doses of Radioiodine Ablation Therapy
Endocrinology and Metabolism. 2020;35(3):602-609   Crossref logo
Link1 Link2 Link3

Clinical outcomes of patients with T4 or N1b well-differentiated thyroid cancer after different strategies of adjuvant radioiodine therapy
Scientific Reports. 2019;9(1):   Crossref logo
Link1 Link2 Link3

Disease outcomes and nodal recurrence in patients with papillary thyroid cancer and lateral neck nodal metastases
ANZ Journal of Surgery. 2013;84(4):240-244   Crossref logo
Link1

Radioiodine Ablation for Differentiated Thyroid Cancer—None, One Dose or Two?
Clinical Oncology. 2010;22(2):131-135   Crossref logo
Link1 Link2

Re: “Long-Term Outcomes of Patients with Papillary Thyroid Cancer Undergoing Remnant Ablation with 30 Millicurie Radioiodine” by Mujammami et al. (Thyroid 2016;26:951–958): Patient Cohort Definition Makes No Sense
Thyroid. 2017;27(4):591-591   Crossref logo
Link1 Link2

Health outcomes of children fathered by patients treated with radioiodine for thyroid cancer
Clinical Endocrinology. 2009;71(6):880-883   Crossref logo
Link1

Response to Tulchinsky and Avram re: “Long-Term Outcomes of Patients with Papillary Thyroid Cancer Undergoing Remnant Ablation with 30 Millicurie Radioiodine”
Thyroid. 2017;27(4):592-592   Crossref logo
Link1 Link2

Long-Term Outcomes of Patients with Papillary Thyroid Cancer Undergoing Remnant Ablation with 30 milliCuries Radioiodine
Thyroid. 2016;26(7):951-958   Crossref logo
Link1 Link2

Post-surgical Use of Radioiodine (131I) in Patients With Papillary and Follicular Thyroid Cancer and the Issue of Remnant Ablation: A Consensus Report
Yearbook of Endocrinology. 2006;2006:299-303   Crossref logo
Link1 Link2

Post-surgical Use of Radioiodine (131I) in Patients With Papillary and Follicular Thyroid Cancer and the Issue of Remnant Ablation: A Consensus Report
Yearbook of Surgery. 2006;2006:151-152   Crossref logo
Link1 Link2